NYSE:NBY NovaBay Pharmaceuticals (NBY) Stock Price, News & Analysis → The attacks will come for me after releasing this… (From Porter & Company) (Ad) Free NBY Stock Alerts $2.51 -0.06 (-2.33%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$2.23▼$2.6950-Day Range$2.51▼$5.9552-Week Range$2.23▼$44.80Volume349,770 shsAverage Volume675,848 shsMarket Capitalization$2.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends Get NovaBay Pharmaceuticals alerts: Email Address Ad True Market InsidersExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 About NovaBay Pharmaceuticals Stock (NYSE:NBY)NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.Read More NBY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NBY Stock News HeadlinesJune 11, 2024 | americanbankingnews.comNovaBay Pharmaceuticals (NYSE:NBY) Receives New Coverage from Analysts at StockNews.comJune 11, 2024 | americanbankingnews.comComparing NovaBay Pharmaceuticals (NYSE:NBY) & Royalty Pharma (NASDAQ:RPRX)June 7, 2024 | businesswire.comNovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE AmericanMay 30, 2024 | investorplace.comWhy Is NovaBay Pharmaceuticals (NBY) Stock Down 39% Today?May 29, 2024 | businesswire.comNovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate UpdatesMay 13, 2024 | seekingalpha.comNovaBay Pharmaceuticals, Inc. (NBY) Q1 2024 Earnings Call TranscriptMay 13, 2024 | businesswire.comNovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye SymptomsMay 9, 2024 | businesswire.comNovaBay Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 7, 2024 | businesswire.comNovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through AmazonMay 3, 2024 | businesswire.comNovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024April 22, 2024 | businesswire.comNovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova SalesApril 19, 2024 | businesswire.comNovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder EquityMarch 28, 2024 | seekingalpha.comNovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call TranscriptMarch 26, 2024 | benzinga.comNovaBay Pharmaceuticals: Q4 Earnings InsightsMarch 26, 2024 | finance.yahoo.comNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial ResultsMarch 25, 2024 | businesswire.comNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024March 14, 2024 | businesswire.comNovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023February 21, 2024 | markets.businessinsider.comNioBay Metals closes option agreement to acquire Foothills propertySee More Headlines Receive NBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSE:NBY CUSIPN/A CIK1389545 Webnovabay.com Phone510-899-8800Fax510-474-1577Employees24Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($109.0910) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,640,000.00 Net Margins-80.76% Pretax Margin-79.99% Return on Equity-304.39% Return on Assets-81.20% Debt Debt-to-Equity RatioN/A Current Ratio0.92 Quick Ratio0.75 Sales & Book Value Annual Sales$14.73 million Price / Sales0.18 Cash FlowN/A Price / Cash FlowN/A Book Value$4.25 per share Price / Book0.59Miscellaneous Outstanding Shares1,080,000Free Float1,081,000Market Cap$2.71 million OptionableNot Optionable Beta1.90 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Justin M. Hall Esq. (Age 46)President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director Comp: $364.15kMr. Tommy Law (Age 39)Controller, Interim CFO & Treasurer Comp: $155.48kKey CompetitorsKiora PharmaceuticalsNASDAQ:KPRXElevai LabsNASDAQ:ELABKintara TherapeuticsNASDAQ:KTRAVaxxinityNASDAQ:VAXXAvalo TherapeuticsNASDAQ:AVTXView All Competitors NBY Stock Analysis - Frequently Asked Questions How have NBY shares performed in 2024? NovaBay Pharmaceuticals' stock was trading at $7.14 at the start of the year. Since then, NBY stock has decreased by 64.8% and is now trading at $2.51. View the best growth stocks for 2024 here. How were NovaBay Pharmaceuticals' earnings last quarter? NovaBay Pharmaceuticals, Inc. (NYSE:NBY) posted its earnings results on Thursday, May, 9th. The company reported ($4.90) earnings per share (EPS) for the quarter. The company had revenue of $2.63 million for the quarter. NovaBay Pharmaceuticals had a negative trailing twelve-month return on equity of 304.39% and a negative net margin of 80.76%. When did NovaBay Pharmaceuticals' stock split? Shares of NovaBay Pharmaceuticals reverse split before market open on Friday, May 31st 2024. The 1-35 reverse split was announced on Friday, May 31st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 31st 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of NovaBay Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other NovaBay Pharmaceuticals investors own include OpGen (OPGN) and Abbott Laboratories (ABT). How do I buy shares of NovaBay Pharmaceuticals? Shares of NBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:NBY) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.